SEC Form 4 · accession 0001209191-16-156140
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phillip G. Febbo
Officer — Chief Medical Officer
Period of report
Aug 15, 2015
Accepted (ET)
Dec 20, 2016 · 5:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 15, 2015 | F | 1,065 | $24.85 | D | 14,307 | D | |
| Common StockF1 | Aug 15, 2016 | F | 1,066 | $27.00 | D | 13,241 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes an aggregate of 11,114 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.